FDA Approves Brinsupri As First Treatment For Non-Cystic Fibrosis Bronchiectasis
ReutersAug 12, 2025 5:32 PM
Aug 12 (Reuters) - Insmed Inc INSM.O:
FDA APPROVES BRINSUPRI™ (BRENSOCATIB) AS THE FIRST AND ONLY TREATMENT FOR NON-CYSTIC FIBROSIS BRONCHIECTASIS, A SERIOUS, CHRONIC LUNG DISEASE
INSMED INC - BRINSUPRI 10 MG AND 25 MG DOSES APPROVED FOR NCFB
INSMED INC - PLANS TO FILE APPLICATIONS FOR BRENSOCATIB IN JAPAN IN 2025
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Applied Materials Q3 Earnings: AI Demand Soars, but Cautious Guidance Triggers After-Hours Selloff
TradingKey - Applied Materials, Inc. (NASDAQ: AMAT) announced its Q3 FY2025 earnings on August 14, 2025, after market close, reporting strong revenue fueled by AI-related semiconductor demand, which beat expectations. However, cautious Q4 guidance, including EPS below analyst estimatesTradingKey
2 hours ago
.jpg)
The Market Game of the Quantitative King: How Renaissance Technologies Locks in Excess Returns Amid the 2025 Turmoil
TradingKey - Founded by mathematician James Simons, Renaissance Technologies LLC is a global leader in quantitative investing, renowned for its data-driven, innovative approach. The firm eschews traditional fundamental analysis, relying instead on advanced mathematical modelsTradingKey
23 hours ago
Bridgewater Associates Q2 2025 13F Analysis: Founder Ray Dalio’s Final Act
TradingKey - Bridgewater Associates, the world’s largest hedge fund and renowned for its macroeconomic analysis, continues to command market respect with its “risk parity” strategy and precise economic cycle timing.TradingKey
23 hours ago
U.S. July CPI Commentary: Obstacles Cleared, Where Will U.S. Stocks Go Next?
TradingKey - On 12 August 2025, the United States released its Consumer Price Index (CPI) data for July. In terms of headline inflation, the CPI rose by 2.7% year-on-year in the month, slightly lower than the expected 2.8%. However, core CPI climbed 3.1% year-on-year, edging past the projected 3.0%.TradingKey
Wed, Aug 13
